Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PMC Group operates as a global specialty chemicals and pharmaceutical manufacturer with activities spanning plastics, consumer products, electronics, packaging, personal care—and notably—pharmaceuticals. Through its acquisition of Yegna Manojavam Drugs and Chemicals Ltd., it manufactures generic APIs including fluoroquinolones at cGMP facilities in India. The group aims to be a major player in cost-effective generics across oncology, neuropsychiatry, GI disorders, pulmonary hypertension, depression and migraine. There are no disclosed proprietary clinical trial results or novel drug candidates from this entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PMC Group.